
    
      -  Objectives: To explore the appropriate dose of a therapeutic hepatitis B vaccine through
           the evaluation of safety, tolerability, and efficacy

        -  Subjects: Chronic hepatitis B carrier with normal ALT range

        -  Study hypothesis: The immune tolerance break and strong immune responses in the chronic
           hepatitis B carrier could be achieved with therapeutic hepatitis B vaccine containing
           novel adjuvant
    
  